Cellectis (CLLS) Stock Chart & Stock Price History $1.54 -0.01 (-0.65%) As of 05/20/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectis Stock Price Performance The Cellectis (CLLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 47.80%, with a year-to-date return of -14.44%. In the past month, the stock has increased 11.59%, reflecting recent market activity. As of the latest close, Cellectis traded at $1.54 with a market cap of $85.60 million and volume of 29,630 shares. Five years ago, the stock traded at $20.88, representing a 92.62% decrease over that period. At the time, it had a market cap of $814.92 million and a volume of 309,183 shares. Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.53%1 Month Performance+11.59%3 Month Performance+0.65%Year-To-Date Performance-14.44%1 Year Performance-47.80%5 Year Performance-92.62% CLLS Stock Chart for Wednesday, May, 21, 2025 CLLS Chart by TradingView Cellectis Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2025$1.55$1.54-0.65%$1.56$1.4629,630 shs$85.60 million05/19/2025$1.58$1.55-1.90%$1.58$1.5325,191 shs$86.16 million05/16/2025$1.46$1.58+8.22%$1.58$1.4749,716 shs$87.82 million05/15/2025$1.38$1.46+5.80%$1.50$1.4225,319 shs$81.15 million05/14/2025$1.41$1.38-2.13%$1.51$1.3727,973 shs$76.71 million05/13/2025$1.51$1.41-6.62%$1.45$1.4152,790 shs$78.37 million05/12/2025$1.60$1.51-5.63%$1.58$1.4624,659 shs$83.93 million05/09/2025$1.53$1.60+4.58%$1.60$1.5324,192 shs$88.93 million05/08/2025$1.53$1.53+0.33%$1.53$1.4624,893 shs$85.04 million05/07/2025$1.58$1.53-3.48%$1.58$1.5321,780 shs$84.77 million Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 05/06/2025$1.60$1.58-1.25%$1.65$1.55142,056 shs$87.82 million05/05/2025$1.59$1.60+0.57%$1.60$1.5440,964 shs$88.93 million05/02/2025$1.61$1.59-1.36%$1.65$1.5867,524 shs$88.43 million05/01/2025$1.65$1.61-1.95%$1.65$1.4978,184 shs$89.66 million04/30/2025$1.59$1.65+3.46%$1.65$1.5644,690 shs$91.44 million04/29/2025$1.54$1.59+3.25%$1.60$1.5242,010 shs$88.38 million04/28/2025$1.53$1.54+0.65%$1.57$1.5161,845 shs$85.60 million04/25/2025$1.51$1.53+1.32%$1.56$1.4881,346 shs$85.04 million04/24/2025$1.46$1.51+3.42%$1.51$1.4632,612 shs$83.93 million04/23/2025$1.44$1.46+1.39%$1.48$1.4359,440 shs$81.15 million04/22/2025$1.38$1.44+4.35%$1.46$1.3744,580 shs$80.04 million04/21/2025$1.45$1.38-4.83%$1.44$1.3625,769 shs$76.71 million Related Companies CKPT Stock Price Chart SNDL Stock Price Chart TRDA Stock Price Chart OLMA Stock Price Chart ARCT Stock Price Chart HRTX Stock Price Chart SEPN Stock Price Chart BNTC Stock Price Chart FULC Stock Price Chart ATYR Stock Price Chart Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLLS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.